Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Emerging Diseases 2018

About conference

Conference Series LLC is hereby pleased to invite all the participants from all over the world to attend the “International Conference on Emerging Infectious Diseases” going to be held on August 31- September 1, 2018 at Zurich, Switzerland. The conference includes prompt presentations, special sessions, workshops, symposium, oral talks, poster presentations and exhibitions. We expect your kind presence at the conference which will discuss the recent emerging diseases, outbreaks, categories, epidemiology, diagnosis, therapeutics etc.

Why to Attend?

Emerging infectious diseases 2018 provides a worldwide platform and recognition to an analyst who enlightens the advanced and unique methods in Infectious Diseases. Dynamic speakers, improvements, and most updated information are particular components of this gathering and personalities from all across the globe focusing on finding out about recent emerging disorders. An expanding number of distinguished methods makes it important to complete propelled research here of irresistible sicknesses. This is going to be your best chance to achieve the biggest collection of members, conduct presentations, disseminate data, meet with potential scientists, trade learning and make an unmistakable imprint by fascinating developments at this event.

ConferenceSeries Ltd is a pioneer and leading scientific event organizer, publishing around 700 Open access journals and conducting over 500 Scientific Meetings all over the globe annually with the support of more than 1000 scientific associations, 80000 editorial board members and 7.5 million followers to its credit. Conference Series is an open resource platform that conducts 3000+ global events including International Conferences, Workshops, Symposia, Trade Shows, Exhibitions and Science Congresses in all the major scientific disciplines, including Clinical, Medical, and pharmaceutical, Engineering, Technology, Business Management and Life Sciences across America, Europe, The Middle East, and Asia Pacific.

Infectious Diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. Infectious diseases may be of water borne, food borne, vector borne, air borne in human beings as well as in plants and animals. Infectious diseases basically emphasize on the pathogenesis of the bacteria and their therapeutic measures, coalesce of branches of microbiology especially clinical and diagnostic microbiology which deals with the cure and prevention of the Infectious diseases. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health.

Targeted audience-

·         Microbiologists

·         Bacteriologists

·         Virologists

·         Parasitologists

·         Mycologist

·         Pathologists

·         Pharmacists

·         Epidemiologists

·         Health care professionals

·         Research scholars

·         Infectious diseases associates and societies.

·         Laboratory technicians

·         Diagnostics companies

·         Drug manufacturing companies

·         Data management companies

·         Medical colleges

·         Infectious Diseases Researchers

 For Scientific Sessions please go through the link: http://emerging-diseases.infectiousconferences.com/call-for-abstracts.php

 For Abstract Submission please go through the link: http://emerging-diseases.infectiousconferences.com/abstract-submission.php

 

Sessions/Tracks

Track 1: Recent emerging infectious diseases

An emerging infectious disease (EID) is a contagious disease whose occurrence has boosted in the last 50 years and chances are there that it could increase in the coming future. Emerging infections account for at least 15% of all human pathogens. EIDs are caused by freshly identified strains that may have emerged from a known infection or transferred to a new community or to a field undergoing conserves metamorphosis, or remerging infections. Of thriving concern are adverse synergistic communication between emerging diseases and other infectious and non-infectious conditions ruling to the evolution of unusual syndemics. Many emerging diseases are zoonotic or synoptic - an animal receptacle incubates the organism, with only random conveyance into human populations. Infectious Diseases square amplitude ataxia caused by microorganism such as viruses, fungi or parasites. Infectious diseases is also, foodborne, vector borne, air borne in  related as  further more  in plants and animals. They essentially affirm on the pathological approach of the microorganism and their therapeutic amplifications, synthesis of division of particularly clinical and diagnostic biology that deals with the cure endurance of the contagious diseases. It exemplifies associate degree progressively mandatory for human pessimism and fatality reason throughout the map.

Related conferences

6thEuro-Global Conferences on Infectious Diseases, during September 07-09, 2017 at Paris, France; World Congress on Infectious Diseases, during    August 21-23, 2017 California, San Francisco, USA; Annual Conference on Rare Diseases and Orphan Drugs, during Oct 26-27, 2016 USA; 3rd International Conference on Influenza, during August 21-22, 2017 Birmingham, UK; 13th World Congress on infection Prevention and Control, during Dec 14-16, 2017 Rome, Italy; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017.

Track 2Sexually transmitted diseases

Sexually transmitted infections (STIs), also referred as venereal diseases (VD), are infections that are generally disseminated by sex, especially vaginal coition, anal sex or oral sex. Most STIs originally do not cause symptoms. This leads to a greater risk of transferring the disease on to others. Expression and evidences of disease may include vaginal discharge, penile discharge, ulcers on or around the genitals, and pelvic pain. STIs attained before or during birth may result in poor fallout for the baby. Some STIs may cause problems with the capacity to conceive. More than 100 different microbial pathogen can cause STIs. Bacterial STIs include chlamydia, gonorrhea, and syphilis among others. Viral STIs include genital herpes, HIV/AIDS, and genital warts among others. Parasitic STIs comprises trichomoniasis among others. While usually spread by sex, some of them can also be spread by non-sexual influence with infected blood and tissues, breastfeeding, or during childbirth. STI assay tests are easily available in the developed world. Most STIs are amenable. Of the most common infections, syphilis, gonorrhea, chlamydia, are curable, while herpes, hepatitis B, HIV/AIDS, and HPV are treatable but not curable. Refusal to certain antibiotics is developing among some strains such as gonorrhea. Not all STIs are emblematic, and symptoms may not appear rapidly after infection. In some cases, a disease can be without any expression, which leaves higher chances of transmission of the disease on to others. Depending on the infection, some untreated STIs can lead to infertility, chronic pain or even death. The occurrence of an STI in prepubescent children may indicate sexual exploitation.

Related conferences

3rd International Conference on Influenza, during August 21-22, 2017 Birmingham, UK; 13th World Congress on infection Prevention and Control, during Dec 14-16, 2017 Rome, Italy; 4th World Congress on Rare Diseases and Orphan Drugs, during June 11-12, 2017 Dublin, Ireland; 2nd International; Conference on Infection Control and Prevention, during Sep 25-26, 2017 Chicago, USA; 5th International congress on Infectious Diseases, during March 1-2, 2017 Berlin, Germany; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during august 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Or Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017leans, USA during November 6-8, 2017.

Track 3:  Paediatric infectious diseases

Pediatric infectious diseases are the contagious diseases which are caused in children of different age groups. Pediatric infectious diseases consultant takes care of the infections occurring in children and the curing approaches vary for children from adults. Spreading of diseases can be through direct contact like touching and indirect contact with the infected person. Droplet transmission is very common. Airborne spreading occurs when germs stay in the air and are carried around on air current.

Related conferences

4th International congress on Infectious Diseases during May 11-12, 2017 Barcelona, Spain; 2nd International Conference on Influenza which September 12-13, 2017 Berlin, Germany; 2nd Ireland; International Conference on HIV/AIDS, STD & STIs October 24-25, 2017 Orlando- FL, USA; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017.

Track 4Vector borne infection

Vectors are living carriers that can transfer infectious diseases between humans or from animals to humans. Many vectors are parasites like bloodsucking insects, which consume on disease-producing pathogen during a blood meal from an infected host and later transfer it into a new host during their following blood meal. Mosquitoes are the famous known disease vector. Others comprises of ticks, sand flies, fleas and some freshwater aquatic snails. Vector-borne diseases are disorders caused by pathogens in human populations. Every year there are more than 5 billion cases and over 3 million deaths from vector-borne diseases such as malaria, dengue, leishmaniasis, Chagas disease, yellow fever and Japanese encephalitis globally. Vector borne diseases report for 15% of overall infectious diseases. Circulation of these diseases is judged by a convoluted potent of environmental and communal factors.

Related conferences

2nd International conference on Flu, during October 18 2017, San Francisco, California, USA; International Conference on Epidemiology & Evolutionary Genetics, during August 21-23 2017, Dublin Ireland; International Conference on HIV/AIDS, STDs & STIs October 24-25, 2017 Orlando- FL, USA 4th International congress on Infectious Diseases during May 11-12, 2017 Barcelona, Spain; 2nd International Conference on Influenza which September 12-13, 2017 Berlin, Germany; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017.

Track 5:  Microbial genomics

Variations in the sequence and structure of genomes from members of a microbial community echo the composite results of mutation, recombination, and selection. With the increasing availability of genome sequences, these results have become better characterized and more efficiently overworked so as to understand the antiquity and progression of microbes and sometimes their close relationships with humans. The resulting intuitions have practical importance for epidemiologic survey, forensics, diagnostics, and vaccine development.

Related conferences

5th International Congress on Bacteriology and Infectious Diseases, during May 25-26, 2017 Chicago, Illinois, USA; 3rd International Conference on Influenza, during August 21-22, 2017 Birmingham, UK, Infection Prevention and control (IPAC), during June 18-21, 2017 Canada; 27th European Congress of Clinical Microbiology and Infectious Diseases, during 22 - 25 April 2017 Austria; 19th International Conference on Clinical Microbiology and Infectious Diseases, during March 11 - 12, 2017 UAE; 3rd International Conference on Flu and Emerging Infectious Diseases, during November 06-07, 2017 Las Vegas; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017.

Track 6: Host and microbial genetics

Microbial genetics is a field within microbiology and genetic engineering. It focuses on the genetics of microorganisms; bacteria, archaea, viruses and some protozoa and fungi. This involves the study of the genotype of microbial species and also their expression in the form of phenotypes. Genetics of bacteria conveys the mechanisms and nature of their heritable information, genome, plasmids, transposons or jumping genes, and phases. Using microbes, protocols are made to insert genes into bacterial plasmids, taking advantage of their fast reproduction, to make biomill for the gene of interest. Such genetically engineered bacteria can produce pharmaceuticals such as insulin, human growth hormone, interferon and blood clotting factors.

Related conferences

3rd International Conference on Influenza, during August 21-22, 2017 Birmingham, UK, Infection Prevention and control (IPAC), during June 18-21, 2017 Canada; 27th     European Congress of Clinical Microbiology and Infectious Diseases, during 22 - 25 April 2017 Austria; 19th International Conference on Clinical Microbiology and Infectious Diseases, during March 11 - 12, 2017 UAE; 3rd International Conference on Flu and Emerging Infectious Diseases, during November 06-07, 2017 Las Vegas; 7th Asia Pacific STD and Infectious Diseases Congress, during October 23-25, 2017 Osaka, Japan; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017.

Track 7:  Modern and unique diagnostics

Medical diagnosis is the process of monitoring which evidence or expression explains a person's symptoms and signs. Laboratory tests may identify organisms directly (e.g., visually, using a microscope growing the organism in culture) or indirectly (e.g., identifying antibodies to the organism). General types of tests include microscopy, culture and immunologic tests (agglutination tests such as latex agglutination, enzyme immunoassays, western blot, precipitation tests and complement fixation tests) and nucleic acid/ non nucleic acid based identification methods. Sub types of diagnoses include clinical, laboratory, radiology, principal and admitting diagnosis. Advanced methods have been implemented to diagnose the infection in any part of the body. Examples include biomarkers/ ELISA test/ chest x ray/ skin biopsy/ tympanometry and tympanocentesis. The asset of testimony, however are often greatly dominated by the cost, as often there is no specific treatment, the cause is obvious, or the outcome of an infection is benevolent.

Related conferences

 2nd  International Conference on Infection Control and Prevention, during Sep 25-26, 2017 Chicago, USA; 5th International congress on Infectious Diseases, during March 1-2, 2017 Berlin, Germany; 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), during May 29-31, 2017 Osaka, Japan; 5th International Congress on Bacteriology and Infectious Diseases, during May 25-26, 2017 Chicago, Illinois, USA; 3rd International Conference on Influenza, during August 21-22, 2017 Birming Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017 UK, Infection Prevention and control (IPAC), during June 18-21, 2017 Canada.

Track 8: Veterinary infectious diseases

Infectious diseases of animals are a major hazard to earthly animal health and welfare and their effective control is necessary for agronomic health, for defending and procuring national and international food supplies and for mitigating rural poverty in developing countries. Some catastrophic livestock diseases are regional in many parts of the world and threats from old and new pathogens continue to rise, with changes to worldwide climate, agricultural approaches and anthropology presenting conditions that are especially supportive for the spread of arthropod-borne diseases into new geographical fields. Zoonotic or phonetic infections that are transmissible either directly or indirectly between animals and humans are on the increase and pose serious additional risks to human health and the recent pandemic status of new influenza A (H1N1) is a topical illustration of the challenge presented by zoonotic viruses.

Related conferences

Annual Conference on Rare Diseases and Orphan Drugs, during Oct 26-27, 2017 USA; 3rd International Conference on Influenza, during August 21-22, 2017 Birmingham, UK; 13th World Congress on infection Prevention and Control, during Dec 14-16, 2017 Rome, Italy; 4th World Congress on Rare Diseases and Orphan Drugs, during June 11-12, 2017 Dublin, Ireland; 2nd International Conference on Infection Control and Prevention, during Sep 25-26, 2017 Chicago, USA; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017.

Track 9: Advancement in vaccine and therapeutics

The exploration of vaccines has led to the near elimination of several important diseases and has a great impact on health for a relatively low cost. However, most vaccines in use today were developed by techniques that were pioneered more than 50 years ago and do not represent the full potential of the field. The introduction of genetic engineering has triggered rapid proposal in vaccine technology and is now prominent to the entry of new products in the merchandise. Global immunization against certain diseases has led to the abolish of smallpox and has almost complete elimination of  many other infectious agents including those causing diphtheria, tetanus, poliomyelitis, measles, mumps, rubella, and Hemophilic influenza type B invasive disease. However, three biggest killers—human immunodeficiency virus (HIV) infection, tuberculosis, and malaria—have not yet been adequately concentrated by a vaccine effective enough to accomplish a similar result. In addition, some common vaccine-preventable diseases such as influenza and pertussis continue to cause significant anguishment and fatality. Current advances in vaccine technology deriving from the function of genetic engineering are now providing the liberty to target new diseases. The use of plasmid-based methods also has the capability to urge the production of reassortant vaccines.

Related conferences

13th World Congress on infection Prevention and Control, during Dec 14-16, 2017 Rome, Italy; 4th World Congress on Rare Diseases and Orphan Drugs, during June 11-12, 2017 Dublin, Ireland; 2nd International Conference on Infection Control and Prevention, during Sep 25-26, 2017 Chicago, USA; 5th International congress on Infectious Diseases, during March 1-2, 2017 Berlin, Germany; 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), during May 29-31, 2017 Osaka, Japan; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017.

Track 10: Public health practice

The Public Health Practice concentration is organized toward students who are able to enlist in courses that utilize amalgam of on-line, video conference, and in person teaching modalities.  Students selecting the public health practice program should hold an academic background in a public health related field and/or experience working or volunteering within at least one public health program. Work includes subject matter in the crux areas of public health: Epidemiology, Biostatistics, Environmental and occupational health, Public health policy and management, Socio-cultural and behavioral aspects of public health.

Related conferences

13th World Congress on Infection Prevention and Control during December 14-16, 2017 Rome, Italy; 4th International congress on Infectious Diseases during May 11-12, 2017 Barcelona, Spain; 2nd International Conference on Influenza which September 12-13, 2017 Berlin, Germany; 2nd International conference on Flu, during October 31- November 02 2016, San Francisco, California, USA; International Conference on Epidemiology & Evolutionary Genetics, during August 21-23, Dublin Ireland; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017.

Track 11: Immunological monitoring of infections

Immunology of infections depicts the battle between pathogens and the host immune system. Immunology is the branch of science concerned with the various aspects related to immune system, innate and acquired immunity. It also deals with laboratory techniques involving the interaction of antigens with specific antibodies. The innate immune system provides early defense and induces an adaptive response to kill the foreign invaders and enact long-term immunological memory.

Related conferences

4th World Congress on Rare Diseases and Orphan Drugs, during June 11-12, 2017 Dublin, Ireland; 2nd International Conference on Infection Control and Prevention, during Sep 25-26, 2017 Chicago, USA; 5th International congress on Infectious Diseases, during March 1-2, 2017 Berlin, Germany; 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), during May 29-31, 2017 Osaka, Japan; 5th International Congress on Bacteriology and Infectious Diseases, during May 25-26, 2017 Chicago, Illinois, USA; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017.

Track 12: Respiratory diseases

Respiratory infection means any of a number of infectious diseases originating in respiratory tract. This type of infection is normally further classified as an upper respiratory tract infection (URI or URTI) or a lower respiratory tract infection (LRI or LRTI). A lower respiratory infection, such as pneumonia, appears to be far more serious conditions than upper respiratory infections, such as the common cold. Respiratory disease is a medical term that focuses on pathological conditions affecting the organs and tissues that makes gas exchange possible in higher organisms, and includes upper respiratory tract, trachea, bronchi, alveoli, pleural cavity and the nerves and muscles of breathing. These diseases range from mild and self-limiting, such as the common cold, to life-threatening like bacterial pneumonia, pulmonary embolism, and lung cancer. The study of respiratory disease is referred as pulmonology. A doctor who specializes in respiratory disease is known as a pulmonologist, a chest medicine specialist, a respiratory medicine specialist, a respirologist or a thoracic medicine specialist. Respiratory ailments can be categorized in many possible ways, including by the organ or tissue involved, by the types or pattern of associated signs and symptoms, or by the cause of the disease.

Related conferences

2nd International Conference on Infection Control and Prevention, during Sep 25-26, 2017 Chicago, USA; 5th International congress on Infectious Diseases, during March 1-2, 2017 Berlin, Germany; 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), during May 29-31, 2017 Osaka, Japan; 5th International Congress on Bacteriology and Infectious Diseases, during May 25-26, 2017 Chicago, Illinois, USA; 3rd International Conference on Influenza, during August 21-22, 2017 Birmingham, Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017.UK, Infection Prevention and control (IPAC), during June 18-21, 2017 Canada.

Track 13: Computational biology approach

Computational biology is also called as systems biology. It is the computational and mathematical modeling of complex biological systems. It is a biology-based interdisciplinary area of research that target on convoluted interactions within biological systems, using holistic methods to biological research. Particularly from year 2000 onwards, this study has been used widely in biology in a variety of aspects. The Human Genome Project is an example of applied systems thinking in biology which has resulted in fresh and synergistic ways of working on problems in the field of genetics. One of the excel ambition of computational biology is to model and find emergent properties, properties of cells, tissues and organisms working as a system whose theoretical description is only possible using techniques which fall under the roof of computational biology. These generally involve metabolic networks or cell signaling networks.

Related conferences

4th International congress on Infectious Diseases during May 11-12, 2017 Barcelona, Spain; 2nd International Conference on Influenza which September 12-13, 2016 Berlin, Germany; 2nd International conference on Flu, during October 31- November 02 2016, San Francisco, California, USA; International Conference on Epidemiology & Evolutionary Genetics, during August 21-23, Dublin Ireland; International Conference on HIV/AIDS, STDs & STIs October 24-25, 2017 Orlando- FLU, USA; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017.

Track 14: Ebola and zika viral infections

Ebola viral infection is caused by virus transmitted through body fluids and through air. It occurs rarely but it is very lethal which results in death and several outbreaksEbola virus disease symptoms are very severe which appears in 2-3 days. Ebola primary symptoms include fever, sore throat, muscular pain and headaches then followed by vomiting, diarrhea, rash, decreased function of the liver and kidneys then loss of blood internally and externally finally leading to low blood pressure and fluid loss resulting in death. Zika virus disease is caused by a virus transmitted primarily by aedes mosquitoes. Individual with zika viral disease can have symptoms including rashes, mild fever, muscle and joint pain and malaise or headache.

Related conferences

5th International Congress on Bacteriology and Infectious Diseases, during May 25-26, 2017 Chicago, Illinois, USA; 3rd International Conference on Influenza, during August 21-22, 2017 Birmingham, UK, Infection Prevention and control (IPAC), during June 18-21, 2017 Canada; 27th European Congress of Clinical Microbiology and Infectious Diseases, during 22 - 25 April 2017 Austria; 19th International Conference on Clinical Microbiology and Infectious Diseases, during March 11 - 12, 2017 UAE; 3rd International Conference on Flu and Emerging Infectious Diseases, during November 06-07, 2017 Las Vegas; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017.

Track 15: Blood stream infections or blood poisoning

Blood stream infections/ blood poisoning occurs when a bacterial infection elsewhere in the body such as in the lungs or skin which enters the blood stream. This is dangerous because the bacteria and their toxins can be carried through the blood stream to the entire body. It is a very serious condition that can lead to organ failure and even death. Blood poisoning requires immediate treatment. Unless it is treated quickly, the bacteria in the blood can cause sepsis. The symptoms of blood poisoning are similar to that of cold or of the flu.

Related conference

Annual Conference on Rare Diseases and Orphan Drugs, during Oct 26-27, 2016 USA; 3rd International Conference on Influenza, during August 21-22, 2017 Birmingham, UK; 13th World Congress on infection Prevention and Control, during Dec 14-16, 2017 Rome, Italy; 4th World Congress on Rare Diseases and Orphan Drugs, during June 11-12, 2017 Dublin, Ireland; 2nd International Conference on Infection Control and Prevention, during Sep 25-26, 2017 Chicago, USA; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017.

Track 16: Urinary tract infections

Urinary tract infections are the infections which are observed in any part of the urinary system (kidneys, ureters, bladder and urethra). Mostly infections are observed in the lower urinary tract (bladder and urethra). Women are at greater risk than men. The most common cause of infection is Escherichia coli, though other bacteria or fungi may rarely be the cause. Risk factors include sexual intercourse, diabetes, obesity, and family history.

Related conferences

7th Asia Pacific STD and Infectious Diseases Congress, during October 23-25, 2017 Osaka, Japan; 13th World Congress on Infection Prevention and Control during December 14-16, 2017 Rome, Italy; 4th International congress on Infectious Diseases during May 11-12, 2017 Barcelona, Spain; 2nd International Conference on Influenza which September 12-13, 2016 Berlin, Germany; 2nd International conference on Flu, during October 31- November 02 2016, San Francisco, California, USA; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017.

Track 17: Surgical site infections

Surgical site infections are the infections which may occur within 30 days after the operation and are observed in the parts of skin and subcutaneous tissue of the incision.

Related conferences

13th World Congress on infection Prevention and Control, during Dec 14-16, 2017 Rome, Italy; 4th World Congress on Rare Diseases and Orphan Drugs, during June 11-12, 2017 Dublin, Ireland; 2nd International Conference on Infection Control and Prevention, during Sep 25-26, 2017 Chicago, USA; 5th International congress on Infectious Diseases, during March 1-2, 2017 Berlin, Germany; 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), during May 29-31, 2017 Osaka, Japan; 5th International Congress on Bacteriology and Infectious Diseases, during May 25-26, 2017 Chicago, Illinois, USA; 3rd International Conference on Influenza, during August 21-22, 2017 Birmingham, UK, Infection Prevention and control (IPAC), during June 18-21, 2017 Canada; 27th European Congress of Clinical Microbiology and Infectious Diseases, during 22 - 25 April 2017 Austria; 19th International Conference on Clinical Microbiology and Infectious Diseases, during March 11 - 12, 2017 UAE; 3rd International Conference on Flu and Emerging Infectious Diseases, during November 06-07, 2017 Las Vegas.

Track 18: Global trends in emerging infectious diseases

An Infectious disease whose occurrence has increased in the past decades or threatens to increase is termed as emerging. These diseases include new infections, previously unrecognized infections and old infections reappearing due to antimicrobial resistance, public health issues and unhygienic conditions.

Related conferences

13th World Congress on infection Prevention and Control, during Dec 14-16, 2017 Rome, Italy; 4th World Congress on Rare Diseases and Orphan Drugs, during June 11-12, 2017 Dublin, Ireland; 2nd International Conference on Infection Control and Prevention, during Sep 25-26, 2017 Chicago, USA; 5th International congress on Infectious Diseases, during March 1-2, 2017 Berlin, Germany; 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), during May 29-31, 2017 Osaka,     Japan; 5th International Congress on Bacteriology and Infectious Diseases, during May 25-26, 2017 Chicago, Illinois, USA; 3rd International Conference on Influenza, during August 21-22, 2017 Birmingham, UK, Infection Prevention and control (IPAC), during June 18-21, 2017 Canada; 27th European Congress of Clinical Microbiology and Infectious Diseases, during 22 - 25 April 2017 Austria; 19th International Conference on Clinical Microbiology and Infectious Diseases, during March 11 - 12, 2017 UAE; 3rd International Conference on Flu and Emerging Infectious Diseases, during November 06-07, 2017 Las Vegas.

Track 19: Neuro infectious diseases

Viral and immune mediated disorders of the nervous system are amongst the most threatening neurological disorders. The most common neuro immune disorder is multiple sclerosis whereas HIV is the most common viral infection of the nervous system. Common to both disorders is the dynamic loss of neurons, leading to significant intellectual and motor dysfunction.

Related conferences

3rd International Conference on Influenza, during August 21-22, 2017 Birmingham, UK; 13th World Congress on infection Prevention and Control, during Dec 14-16, 2017 Rome, Italy; 4th World Congress on Rare Diseases and Orphan Drugs, during June 11-12, 2017 Dublin, Ireland; 2nd International; Conference on Infection Control and Prevention, during Sep 25-26, 2017 Chicago, USA; 5th International congress on Infectious Diseases, during March 1-2, 2017 Berlin, Germany; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Or Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017leans, USA during November 6-8, 2017.

Track 20: Global distribution and transmission

An infectious disease is transmitted from one person to another by direct or indirect means. Several types of bacteria, virus, fungi, and parasites can all cause infectious disease. Malaria, measles, and respiratory illnesses are examples of infectious diseases. The greatest exposure of new diseases comes from zoonoses-pathogens that circulate among wild animals and are seldom transferred to humans by intermediate invertebrate hosts that are susceptible to climatic conditions. Interpretive tools that are based on geographical information systems and that can assimilate distantly sensed information about the environment offer the potential to define the limiting conditions for any disease in its indigenous region for which there are at least some distribution data. The direction, intensity or likelihood of its spread to new regions could then be analyzed, potentially permitting disease budding-warning systems to be developed.

Related conferences

2nd International Conference on Infection Control and Prevention, during Sep 25-26, 2017 Chicago, USA; 5th International congress on Infectious Diseases, during March 1-2, 2017 Berlin, Germany; 4th    International Conference on Chronic Obstructive Pulmonary Disease (COPD), during May 29-31, 2017 Osaka, Japan; 5th International Congress on Bacteriology and Infectious Diseases, during May 25-26, 2017 Chicago, Illinois, USA; 3rd International Conference on Influenza, during August 21-22, 2017 Birmingham, UK, Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017 Infection Prevention and control (IPAC), during June 18-21, 2017 Canada.

Track 21: Influenza virus or flu 

Influenza is a communicable respiratory disorder caused by flu viruses. It can range from moderate to serious illness, and sometimes lead to death. The flu is absolutely different from a cold. The regular symptoms include: a high fever, running nose, sore throat, muscle pains, headache, coughing, and feeling tired. Three types of influenza viruses hits the community, called Type A, Type B, and Type C. Usually, the virus is transmitted through the air from coughs or sneezes. The disease can be diagnosed by testing the throat, sputum, or nose for the virus. Various rapid tests are convenient. A polymerase chain reaction that detects the virus's RNA is more reliable.

Related conferences

 2nd International Conference on Infection Control and Prevention, during Sep 25-26, 2017 Chicago, USA; 5th International congress on Infectious Diseases, during March 1-2, 2017 Berlin, Germany; 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), during May 29-31, 2017 Osaka, Japan; 5th International Congress on Bacteriology and Infectious Diseases, during May 25-26, 2017 Chicago, Illinois, USA; 3rd International Conference on Influenza, during August 21-22, 2017 Birming Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017 UK, Infection Prevention and control (IPAC), during June 18-21, 2017 Canada.

Track 22: Re-emergence of neglected infectious diseases

Cholera is a disorder of the small intestine caused by some strains of the bacterium Vibrio cholerae. The peculiar symptom is multiple watery diarrhoea that lasts for few days. Vomiting and muscle cramps can also occur. Diarrhoea can be so severe that it may lead within hours to severe dehydration and electrolyte imbalance. It spreads mostly by contaminated water and food that has been spoiled with human faeces containing the bacteria. Monkeypox is a contagious disease caused by the monkeypox virus. Monkeypox is generally transmitted to humans from rodents, pets, and primates through contact with the animal's blood. An aves adapted strain of H5N1 is a great pathogenic causative agent of H5N1 flu, locally known as avian influenza ("bird flu"). It is enzootic in many bird populations.

Related conferences

4th International congress on Infectious Diseases during May 11-12, 2017 Barcelona, Spain; 2nd International Conference on Influenza which September 12-13, 2016 Berlin, Germany; 2nd International conference on Flu, during October 31- November 02 2016, San Francisco, California, USA; International Conference on Epidemiology & Evolutionary Genetics, during August 21-23, Dublin Ireland; International Conference on HIV/AIDS, STD & STIs October 24-25, 2017 Orlando- FL, USA; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017.

Track 23: Rare infectious diseases

Rare diseases caused by causative agents rather than genetic or environmental factors.

Related conferences

2nd International conference on Flu, during October 31- November 02 2016, San Francisco, California, USA; International Conference on Epidemiology & Evolutionary Genetics, during August 21-23, Dublin Ireland; International Conference on HIV/AIDS, STDs & STIs October 24-25, 2017 Orlando- FL, USA; 4th International congress on Infectious Diseases during May 11-12, 2017 Barcelona, Spain; 2nd International Conference on Influenza which September 12-13, 2016 Berlin, Germany; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017.

Track 24: Market analysis and manufactures of infectious diseases

The market report formulate information from divergent origin into a tenacious unit that includes an overview, global assumption of infectious diseases, infectious diseases by type, diagnosis and cure, lime lighting pharmaceutical and diagnostic products, and an applicable patents section. Report is organized by type of infectious diseases and appropriate treatments, both recent and predictable. Global Market Reports of inevitable disabilities is a full investigation and stream inclines in the irresistible disorders remedial and indicative market, industry development drivers, triggered treatments and stipulations. It gives advertise bump to the coming years. It incorporates checking of late advancements in modernization for contamination assay and treatment. Market reports likewise incorporate an investigation of small scale and large scale variables important for the current market holders and new contestants side by side.

Related conferences

5th International Congress on Bacteriology and Infectious Diseases, during May 25-26, 2017 Chicago, Illinois, USA; 3rd International Conference on Influenza, during August 21-22, 2017 Birmingham, UK, Infection Prevention and control (IPAC), during June 18-21, 2017 Canada; 27th European Congress of Clinical Microbiology and Infectious Diseases, during 22 - 25 April 2017 Austria; 19th International Conference on Clinical Microbiology and Infectious Diseases, during March 11 - 12, 2017 UAE; 3rd International Conference on Flu and Emerging Infectious Diseases, during November 06-07, 2017 Las Vegas; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017.

Track 25: Public awareness

Public awareness of infectious diseases plays a crucial role in disease control; a lack of feasible information of infectious diseases leads to reduced detection rates, the disruption of treatment, partiality and stigma. Therefore, to abolish the spread of such epidemic calamity the government of respective countries launches specific national disease control plans, using posters, advertisements on television and printed media and other methods to promote the awareness of these diseases in the local population. The appraisal of the awareness levels in rural areas is very important because it help to determine the result of preceding prevention steps made by the government and benchmark the need for arbitrations.

Related conferences

7th Asia Pacific STD and Infectious Diseases Congress, during October 23-25, 2017 Osaka, Japan; 13th World Congress on Infection Prevention and Control during December 14-16, 2017 Rome, Italy; 4th International congress on Infectious Diseases during May 11-12, 2017 Barcelona, Spain; 2nd International Conference on Influenza which September 12-13, 2017 Berlin, Germany; 2nd International conference on Flu, during October 31- November 02 2017, San Francisco, California, USA; Bacteriology, Infectious Diseases & Control, Dallas USA during September 18-19, 2017; 5th World Congress on Bacteriology, Rome, Italy during October 16-17, 2017; Neglected Tropical Diseases Conference: Current and Future Challenges, Chicago, Illinois, USA during November 2-3, 2017; International Conference on Influenza Orlando, USA during March 28-29, 2017; 2nd International Conference on Worldwide Infectious Diseases New Orleans, USA during November 6-8, 2017.

 

 

Market analysis

Summary

Emerging Diseases 2018 is an ideal and open podium to explore and attain the knowledge in the field of life science. This conference brings together professors, researchers, scientists, students in all areas of medical science, life science, pharmaceuticals enable an international forum to explore the ongoing and approved research. Conference Series LLC is delighted to invite you to be a part and register for the “International conference on Infectious diseases” scheduled on august 31st – September 1st 2018 at Zurich, Switzerland. The goal was to bring together a multidisciplinary group to identify important issues relating to Infection in Europe, United States, and Asia Pacific across the world. This summary provides the recommendations from the conference that will be used to develop an action plan for the Infectious Diseases. It includes actions proposed by plenary speakers, roundtable faculty and conference participant.

The organizing committee member is regulating for an exciting and informative conference program which include complete lectures, symposium, workshops on variety of topics, poster presentations and various programs for the participants from all over the world.

For more details, please visit: http://emerging-diseases.infectiousconferences.com/

Importance and scope-

Market analysis and values of emerging infectious diseases entwine the changes driven by science and technology; Provides details on market size forecasts incorporating scientific and technological developments in medical, clinical, pharmaceuticals, engineering, science, technology and business fields; Identifies market growth drivers providing insights; Informs product trends, market size, scientific research details, and global perspectives demography wise; Collects data on recognized experts, target audience, universities, societies, associations, organizations, industries, companies, and funding institutions; Enables clients to take advantage of emerging opportunities.

Healthcare-acquired infections are one of the most common complications of health care. They are a significant patient safety issue, and can also be an Occupational Health and Safety issue. A well-functioning Infection Prevention and Control program helps minimize these risks for patients. Each health care worker needs to understand his or her role in infection prevention and control, integrate it into daily activities, and articulate this role to others.

Why Zurich?

Zurich, being the capital and largest city in Switzerland, it is the global city and one among the largest financial centers of the world. According to several surveys from 2006 to 2008, Zürich was named the city with the best quality of life in the world as well as the wealthiest city in Europe. Many museums and art galleries can be found in the city, including the Swiss. As a “metropolis of experiences” by the water, with a magnificent view of the snowcapped Alps on the horizon, Zurich offers a unique mixture of attractions. The lively tradition of merchant guilds in Zurich is dating back to the middle Ages. Equally impressive are their fine guild houses and guildhalls – such as the Zunfthaus zur Waag, open since at least 1303. Zurich’s shopping mile has contributed largely to the city's reputation as an El Dorado for shoppers and is a top address for international fashion labels, jewelry and watches.

Infectious Disease Diagnostic Market

Rising incidence of infectious diseases, growing adoption of advanced molecular techniques, and increasing interventions from government and non-profile organization to reduce infectious disease in underdeveloped regions are endorsing the growth of infectious disease diagnosis market. In addition, the companies promoting in the disease diagnostic technologies are focusing on the development of novel diagnostics, which eventually provides pace to the market growth. However, lack of awareness for novel diagnostic solution, absence of compiled regulatory guidelines and lower positivity rates due to inferior laboratory conditions would hinder the growth of infectious disease diagnostics market.

The emerging economies are the prime contributors of laboratory test segment especially in Asia-Pacific region, owing to high positivity rates. Laboratory test are first line of diagnostics referred by physicians which includes, blood test, urine test, spinal tap, throat swabs, and stool test. By techniques, the molecular diagnostic techniques such as PCR, and other nucleic acid amplification test would gain prominence in developed region. Based on condition, the bacterial infections, GI infections and Sexually transmitted disease have the largest share in infectious disease testing market, owing to high prevalence especially in emerging economies. Countries belonging to Asia-Pacific and Africa regions have largest share in infectious disease diagnosis market due to high prevalence and incidence of infectious diseases especially sexually transmitted disease and bacterial infections. North America and European countries will ahead towards the adoption on high end infectious disease diagnostic with the help of molecular technologies. This increasing adoption of premium diagnostic techniques would sustain the market share of infectious disease diagnostics in developed region.

                           

Current outbreaks -

·         Cholera – Nigeria

·         Meningococcal septicemia – Saudi Arabia

·         Human infection with avian influenza – China

·         Yellow fever – Brazil

·         Seoul virus – Canada and USA

Members associated with infectious diseases-

  • Infectious Diseases Society has 707 members
  • Global Public Health is having 106913 members
  • Members Pediatric Infectious Disease and Immunology has 3291 members
  • European Society of Clinical Microbiology and Infectious Diseases has 3438 members
  • Centre for Infectious Diseases and Policy includes 218 members

Societies and associations related to emerging infectious diseases-

  • European Society of Clinical Microbiology and Infectious Diseases
  • British Society for Immunology
  • European Society for pediatric Infectious diseases
  • British Society for Immunology
  • Worldwide societies for infectious diseases is about 150
  • British Infection Association
  • Healthcare Infection Society

Universities related to emerging infectious diseases-

·         University of Cambridge

·         Columbia university

·         University of Liverpool

·         Kings college of London

·         Oslo university

·         Uppsala university

·         Imperial college of London

·         Infectious diseases society of America

·         University of Gothenburg

·         University of Pittsburgh

·         Queensland university of technology

·         Medical college of Georgia reagents university

·         University of Otago

·         University of Sheffield

The major key players or companies present in the Infectious Diseases Therapeutics Market with their new product (vaccines, drugs) launches and innovations include

• Agenus Inc.
• GlaxoSmithKline
• Pfizer
• Novartis
• Transgene
• Bristol-Myers Squibb,
• Eli Lilly
• Mitsubishi Tanabe
• Sanof

These players are major influencers influencing the market dynamics of the global Infectious Disease Treatment Market through their research and product innovations.

                                 

Market research

About 80 infectious diseases and viruses, including their scientific background, clinical significance and market needs for both current and emerging tests, vaccines, drugs and extensive listings of companies developing or marketing new technologies and products. Global infectious diseases market is expected to reach 25.9 billion by 2022 according to a new report by researchers. Introduction of technologically advanced diagnostic devices along with associated benefits such as rapid result availability, The largest market share belongs to antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market.  Fungal disease treatments will experience a slightly higher compound annual growth rate (CAGR) of 6.2%, from $4.6 billion in 2009 to $6.2 billion in 2017 

 

 

 

 

 

 

 

 

 

 

Past Conference Report

Infection Congress 2017

Infection Congress 2017

Infection Congress-2017 Past Conference Report

Sensing the raising importance of infectious diseases prevention, control, treatment and cure, Conference Series LLC hosted 4th International Congress on Infectious Diseases (Infection Congress 2017), during May 11-12, 2017 in Barcelona, Spain with the theme Exploring recent outbreaks, advances and technologies in treatment and research of infectious diseases”. The conference was successful in gathering eminent speakers from various reputed organizations and their paramount talks enlightened the gathering. The pragmatic meet organized by Conference Series LLC received generous response from the Editorial Board Members of the Journals as well as expertise from Academia, Talented Researchers and Young Student Community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive event. The conference was marked with the presence of Renowned Speakers, Young Researchers, Students and Business Delegates driving the two day event into the path of success with thought provoking keynote and plenary presentations.

The Infection Congress-2017 Conference was carried out through various sessions with discussions on the following thought provoking major scientific tracks:

  • Infection and Immune System
  • Host and Microbial Genetics
  • Infections from Contaminated Pharmaceuticals or Counterfeit Medications
  • Foodborne and Waterborne Illnesses
  • Emergence and Pathogenesis of Coronaviruses
  • Nosocomial Infections
  • Pediatric Infections
  • Hemorrhagic Fevers
  • New or Rapid Diagnostics
  • Therapeutic Interventions in Rare Diseases
  • Antimicrobial Resistance
  • Infection Control and Epidemiology
  • Drug Metabolism in Microorganisms
  • New Opportunities for Tuberculosis Control

Infection Congress 2017 Proceedings

·                     Key Note Forum

·                     Tracks

·                     Posters and Accepted Abstracts

The conference was embarked with an opening ceremony followed by Keynote presentations, Workshop and a series of lectures delivered by both honorable guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

1. Moderators

  • Vaneza Leah Espino, UP-Philippine General Hospital, Philippines

2. Session Chairs

·         Dr. Imran Khan, University of California, Davis, USA

·         Walter Fierz, Labormedizinisches zentrum Dr Risch, Liechtenstein

3. Poster Judges

·         Dr. Imran Khan, University of California, Davis, USA

·         Dr. Ashok Rattan, Pathkind Diagnostics Pvt Ltd, New Delhi, India

4. Keynote Presentations

·         Dr. Ashok Rattan, Pathkind Diagnostics Pvt Ltd, New Delhi, India

·         Dr. Imran Khan, University of California, Davis, USA

5. Workshop

·         Workshop on “Nitrofurantoin Sensitivity Pattern PAN India of Uropathogens” by Ashok Rattan, Pathkind Diagnostics Pvt Ltd, New Delhi, India

 

6. Young Researchers Forum

·         Hailay Gesesew, Flinders University, Australia

·         Ambak Kumar Rai, Motilal Nehru National Institute of Technology, India

·         Oscar Guanya, Busia County Referral Hospital, Kenya

7. Best Poster Awards

Conference Series LLC offers its heartfelt appreciation to Societies and Organizations and is obliged to the Organizing Committee Members, Adepts of Field, Various Outside Experts, Company Representatives and other eminent personalities who interlaced with Conference Series LLC in supporting and making the conference a grandiose event.

Your rejoinder is our inspiration, keeping this motto in mind and being witnessed the triumph of Infection Congress 2017, Conference Series LLC is delighted to announce the next event, “International conference on Emerging Infectious Diseases” to be held during august 31st – September 1st , 2018 at Zurich, Switzerland.

Let us meet again @Emerging Infectious Diseases 2018

 


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date 31st August-1st September 2018

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Supported By

Journal of Infectious Diseases & Therapy Journal of Air & Water Borne Diseases Journal of Bacteriology & Parasitology Journal of Epidemiology: Open Access

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos